medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2017-9-124-130medsovet-1967Research ArticleАЛЛЕРГОЛОГИЯ И ИММУНОЛОГИЯALLERGOLOGY AND IMMUNOLOGYРЕКУРРЕНТНЫЕ РЕСПИРАТОРНЫЕ ИНФЕКЦИИ У ДЕТЕЙ ПРИЧИНЫ, СВОЕВРЕМЕННАЯ ДИАГНОСТИКА, ЭФФЕКТИВНОЕ ЛЕЧЕНИЕ И ПРЕДОТВРАЩЕНИЕ РЕЦИДИВИРОВАНИЯRECURRENT RESPIRATORY INFECTIONS IN CHILDREN: CAUSES, MODERN DIAGNOSTICS, EFFECTIVE TREATMENT AND PREVENTION OF RECURRENCEВЕЛИКОРЕЦКАЯМ. Д.VELIKORETSKAYAM. D.

к.м.н.

PhD in Medicine

Первый Московский государственный медицинский университет им. И.М. СеченоваРоссияFirst Moscow State Medical University named after I.M. SechenovRussian Federation20172107201709124130Copyright © ВЕЛИКОРЕЦКАЯ М.Д., 20172017ВЕЛИКОРЕЦКАЯ М.Д.VELIKORETSKAYA M.D.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1967

Дети являются группой риска рекуррентных респираторных инфекций среди других возрастных групп. Рецидивирование респираторных инфекций может приводить к формированию хронических очагов воспаления, персистированию вирусов, нарушению физического и психомоторного развития. Нередко для лечения ОРИ неправомочно назначают антибиотики, что приводит лишь к формированию антибиотикорезистентности, сенсибилизации и не предотвращает осложнения, а подчеркивает необходимость поиска альтернативных стратегий лечения рецидивирующих ОРИ. Ограничивающим фактором применения вакцин является наличие сотен различных серотипов вирусов, что делает невозможным создание вакциныпротив каждого отдельного возбудителя. В профилактике рецидивирующих ОРИ на передний план выходит использование бактериальных лизатов для повышения неспецифического иммунитета

Children are at risk of recurrent respiratory infections compared to other age groups. Recurrence of respiratory infections can lead to the formation of chronic foci of inflammation, persistence of viruses, disruption of physical and psychomotor development. That often leads to inappropriate prescription of antibiotics for the treatment of ARI and the formation of antibiotic resistance, sensitization and failure to prevent complications. The situation demands searching for alternative strategies for the treatment of recurrent ARIs. The limiting factor in the use of vaccines is the presence of hundreds of different viral serotypes, thus making it impossible to create a vaccine against each individual pathogen. Therefore, the crucial role in the prevention of recurrent ARI belongs to bacterial lysates which improve nonspecific immunity

инфекциядыхательные путиверхние дыхательные путириносинуситбактериальный иммуномодуляторантибиотикиinfectionrespiratory tractupper respiratory tractrhinosinusitisbacterial immunomodulatorantibioticsReferencesОколышева Н.В., Кистенева Л.Б., Выжлова Е.Н. и соавт. Эффективность виферонотерапии у детей раннего возраста с острой респираторной вирусной инфекцией. Российский вестник перинатологии и педиатрии, 2015, 2.Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014, 11(3): 404–6. doi: 10.1513/ AnnalsATS.201311-405PS. [PubMed: 24673696]/Ключников С.О., Зайцева О.В., Османов И.М. и др. Острые респираторные заболевания у детей. Пособие для врачей. — М., 2009.-48с.Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ, 2008, 86(5): 408-16. [PubMed: 18545744]Макарова З.С., Голубева Л.Г. Оздоровление и реабилитация часто болеющих детей в дошкольных учреждениях. — М.: Гуманитар, изд. Центр ВЛАДОС, 2004.-270 с.Wardlaw T, Salama P, Johansson EW, Mason E. Pneumonia: the leading killer of children. Lancet, 2006, 368(9541): 1048-50. doi: 10.1016/S0140-6736(06)69334-3. [PubMed: 16997649]Wybran J, Libin M, Schandene L. Activation of natural killer cells and cytokine production in man by bacterial extracts. Immunopharmacol Immuno toxi col, 1989, 11(1): 17-32. doi: 10.3109/08923978909082140. [PubMed: 2503554]Wybran J, Libin M, Schandene L. Activation of natural killer cells and cytokine production in man by bacterial extracts. Immunopharmacol Immuno toxi col, 1989, 11(1): 17-32. doi: 10.3109/08923978909082140. [PubMed: 2503554]Alyanakian MA, Grela F, Aumeunier A, Chiavaroli C, Gouarin C, Bardel E, et al. Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes, 2006, 55(1): 179-85. [PubMed: 16380491]Alyanakian MA, Grela F, Aumeunier A, Chiavaroli C, Gouarin C, Bardel E, et al. Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes, 2006, 55(1): 179-85. [PubMed: 16380491]Parola C, Salogni L, Vaira X, Scutera S, Somma P, Salvi V, et al. Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway. PLoS One, 2013, 8(12): e82867. doi: 10.1371/journal. pone.0082867. [PubMed: 24386121]Parola C, Salogni L, Vaira X, Scutera S, Somma P, Salvi V, et al. Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway. PLoS One, 2013, 8(12): e82867. doi: 10.1371/journal. pone.0082867. [PubMed: 24386121]Pasquali C, Salami O, Taneja M, Gollwitzer ES, Trompette A, Pattaroni C, et al. Enhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract. Front Med (Lausanne), 2014, 1: 41. doi: 10.3389/fmed.2014.00041. [PubMed: 25593914]Pasquali C, Salami O, Taneja M, Gollwitzer ES, Trompette A, Pattaroni C, et al. Enhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract. Front Med (Lausanne), 2014, 1: 41. doi: 10.3389/fmed.2014.00041. [PubMed: 25593914]Eggenberger K. Respiratory tract infections most frequently seen in pediatric outpatient care. Ars Medici, 1993, 83: 24-40.Eggenberger K. Respiratory tract infections most frequently seen in pediatric outpatient care. Ars Medici, 1993, 83: 24-40.Bousquet J, Fiocchi A. Prevention of recurrent respiratory tract infections in children using a ribosomal immunotherapeutic agent: a clinical review. Paediatr Drugs, 2006, 8(4): 235–43. [PubMed: 16898854]Bousquet J, Fiocchi A. Prevention of recurrent respiratory tract infections in children using a ribosomal immunotherapeutic agent: a clinical review. Paediatr Drugs, 2006, 8(4): 235–43. [PubMed: 16898854]Schaad UB. Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85. Eur Respira, 2005, 14(95): 74-7. doi: 10.1183/09059180.05.00009506.Schaad UB. Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85. Eur Respira, 2005, 14(95): 74-7. doi: 10.1183/09059180.05.00009506.Thomas CP, Ryan M, Chapman JD, Stason WB, Tompkins CP, Suaya JA, et al. Incidence and cost of pneumonia in medicare beneficiaries. Chest, 2012, 142(4): 973-81. doi: 10.1378/chest.11-1160. [PubMed: 22406959]Thomas CP, Ryan M, Chapman JD, Stason WB, Tompkins CP, Suaya JA, et al. Incidence and cost of pneumonia in medicare beneficiaries. Chest, 2012, 142(4): 973-81. doi: 10.1378/chest.11-1160. [PubMed: 22406959]Colice GL, Morley MA, Asche C, Birnbaum HG. Treatment costs of community-acquired pneumonia in an employed population. Chest, 2004, 125(6): 2140-5. [PubMed: 15189934]Colice GL, Morley MA, Asche C, Birnbaum HG. Treatment costs of community-acquired pneumonia in an employed population. Chest, 2004, 125(6): 2140-5. [PubMed: 15189934]Luan H, Zhang Q, Wang L, Wang C, Zhang M, Xu X, et al. OM85-BV induced the productions of IL-1beta, IL-6, and TNF-alpha via TLR4- and TLR2-mediated ERK1/2/NF-kappaB pathway in RAW264.7 cells. J Interferon Cytokine Res, 2014, 34(7): 526-36. doi: 10.1089/ jir.2013.0077. [PubMed: 24605772]Luan H, Zhang Q, Wang L, Wang C, Zhang M, Xu X, et al. OM85-BV induced the productions of IL-1beta, IL-6, and TNF-alpha via TLR4- and TLR2-mediated ERK1/2/NF-kappaB pathway in RAW264.7 cells. J Interferon Cytokine Res, 2014, 34(7): 526-36. doi: 10.1089/ jir.2013.0077. [PubMed: 24605772]Khattab A, Shaheen M, Kamel T, El Faramay A, El Rahman SA, Nabil D, et al. Burden of pediatric influenza A virus infection post swine-flu H1N1 pandemic in Egypt. Asian Pac J Trop Med, 2013, 6(9): 693-8. doi: 10.1016/S1995-7645(13)60120-0. [PubMed: 23827145]Khattab A, Shaheen M, Kamel T, El Faramay A, El Rahman SA, Nabil D, et al. Burden of pediatric influenza A virus infection post swine-flu H1N1 pandemic in Egypt. Asian Pac J Trop Med, 2013, 6(9): 693-8. doi: 10.1016/S1995-7645(13)60120-0. [PubMed: 23827145]Salami A, Dellepiane M, Crippa B, Mora F, Guastini L, Jankowska B, et al. Sulphurous water inhalations in the prophylaxis of recurrent upper respiratory tract infections. Int J Pediatr Otorhinolaryngol, 2008, 72(11): 1717–22. doi: 10.1016/j. ijporl.2008.08.014. [PubMed: 18817987]Salami A, Dellepiane M, Crippa B, Mora F, Guastini L, Jankowska B, et al. Sulphurous water inhalations in the prophylaxis of recurrent upper respiratory tract infections. Int J Pediatr Otorhinolaryngol, 2008, 72(11): 1717–22. doi: 10.1016/j. ijporl.2008.08.014. [PubMed: 18817987]McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev, 2006, 19(3): 571–82. doi: 10.1128/CMR.00058-05. [PubMed: 16847087]McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev, 2006, 19(3): 571–82. doi: 10.1128/CMR.00058-05. [PubMed: 16847087]Bosch AA, Biesbroek G, Trzcinski K, Sanders EA, Bogaert D. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog, 2013, 9(1): e1003057. doi: 10.1371/journal. ppat.1003057. [PubMed: 23326226]Bosch AA, Biesbroek G, Trzcinski K, Sanders EA, Bogaert D. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog, 2013, 9(1): e1003057. doi: 10.1371/journal. ppat.1003057. [PubMed: 23326226]Keitel K, Alcoba G, Lacroix L, Manzano S, Galetto-Lacour A, Gervaix A. Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland. Swiss Med Wkly. 2014, 144: w13925. doi: 10.4414/smw.2014.13925. [PubMed: 24706389]Keitel K, Alcoba G, Lacroix L, Manzano S, Galetto-Lacour A, Gervaix A. Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland. Swiss Med Wkly. 2014, 144: w13925. doi: 10.4414/smw.2014.13925. [PubMed: 24706389]Greenberg HB, Piedra PA. Immunization against viral respiratory disease: a review. Pediatr Infect Dis J,. 2004, 23(11 Suppl): S254-61. [PubMed: 15577581]Greenberg HB, Piedra PA. Immunization against viral respiratory disease: a review. Pediatr Infect Dis J,. 2004, 23(11 Suppl): S254-61. [PubMed: 15577581]Esposito S, Tagliabue C, Tagliaferri L, Semino M, Longo MR, Principi N. Preventing influenza in younger children. Clin Microbiol Infect. 2012, 18(Suppl 5): 42-9. doi: 10.1111/ j.1469-0691.2012 .03942.x. [PubMed: 22862744]Esposito S, Tagliabue C, Tagliaferri L, Semino M, Longo MR, Principi N. Preventing influenza in younger children. Clin Microbiol Infect. 2012, 18(Suppl 5): 42-9. doi: 10.1111/ j.1469-0691.2012 .03942.x. [PubMed: 22862744]Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA, 2009, 302(7): 758-66. doi: 10.1001/jama.2009.1163. [PubMed: 19690308]Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA, 2009, 302(7): 758-66. doi: 10.1001/jama.2009.1163. [PubMed: 19690308]Hersh AL, Shapiro DJ, Pavia AT, Shah SS. Antibiotic prescribing in ambulatory pediatrics in the UnitedStates. Pediatrics, 2011, 128(6): 1053-61. doi: 10.1542/peds.2011-1337. [PubMed: 22065263]Hersh AL, Shapiro DJ, Pavia AT, Shah SS. Antibiotic prescribing in ambulatory pediatrics in the UnitedStates. Pediatrics, 2011, 128(6): 1053-61. doi: 10.1542/peds.2011-1337. [PubMed: 22065263]Sanchez GV, Roberts RM, Albert AP, Johnson DD, Hicks LA. Effects of knowledge, attitudes, and practices of primary care providers on antibiotic selection, United States. Emerg Infect Dis, 2014, 20(12): 2041-7. doi: 10.3201/eid2012.140331. [PubMed: 25418868]Sanchez GV, Roberts RM, Albert AP, Johnson DD, Hicks LA. Effects of knowledge, attitudes, and practices of primary care providers on antibiotic selection, United States. Emerg Infect Dis, 2014, 20(12): 2041-7. doi: 10.3201/eid2012.140331. [PubMed: 25418868]Cohen AL, Budnitz DS, Weidenbach KN, JerniganDB, Schroeder TJ, Shehab N, et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr, 2008, 152(3): 416–21. doi: 10.1016/j. jpeds.2007.07.041. [PubMed: 18280852]Cohen AL, Budnitz DS, Weidenbach KN, JerniganDB, Schroeder TJ, Shehab N, et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr, 2008, 152(3): 416–21. doi: 10.1016/j. jpeds.2007.07.041. [PubMed: 18280852]Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD.Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ, 2010, 340:2096. doi: 10.1136/bmj.c2096. [PubMed: 20483949]Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD.Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ, 2010, 340:2096. doi: 10.1136/bmj.c2096. [PubMed: 20483949]Piovani D, Clavenna A, Sequi M, Cartabia M, Bortolotti A, Fortino I, et al. Reducing the costsof paediatric antibiotic prescribing in the communityby implementing guideline recommendations. J Clin Pharm Ther, 2013, 38(5): 373-8. doi: 10.1111/jcpt.12068. [PubMed: 23611435]Piovani D, Clavenna A, Sequi M, Cartabia M, Bortolotti A, Fortino I, et al. Reducing the costsof paediatric antibiotic prescribing in the communityby implementing guideline recommendations. J Clin Pharm Ther, 2013, 38(5): 373-8. doi: 10.1111/jcpt.12068. [PubMed: 23611435]Davies A. Fever in children. Nurs Stand, 2014,29(1): 61. doi: 10.7748/ ns.29.1.61.s51. [PubMed: 25182924]Davies A. Fever in children. Nurs Stand, 2014,29(1): 61. doi: 10.7748/ ns.29.1.61.s51. [PubMed: 25182924]Schaad UB, Principi N. The management of recurrent respiratory tract infections in children. Europ Infect Dis, 2012, 6(2): 111-5.Schaad UB, Principi N. The management of recurrent respiratory tract infections in children. Europ Infect Dis, 2012, 6(2): 111-5.Jesenak M, Babusikova E, Ciljakova M, Banovcin P, Rennerova Z. Recurrent respiratory infections in children-definition, diagnostic approach, treatment and prevention. INTECH Open Access Publisher, 2011.Jesenak M, Babusikova E, Ciljakova M, Banovcin P, Rennerova Z. Recurrent respiratory infections in children-definition, diagnostic approach, treatment and prevention. INTECH Open Access Publisher, 2011.Mossad SB. Upper Respiratory Tract Infections, 2013. Available from: http: //www clevelandclinicmeded com/medicalpubs/diseasemanagement/infectious-disease/upper-respiratorytract-infection/Default htm#top 2013.Mossad SB. Upper Respiratory Tract Infections, 2013. Available from: http: //www clevelandclinicmeded com/medicalpubs/diseasemanagement/infectious-disease/upper-respiratorytract-infection/Default htm#top 2013.Korppi M. Recurrent respiratory infections in children: a practical approach for clinical work. Pediatr Pulmonol Suppl, 1997, 16: 144-5. [PubMed: 9443246].Korppi M. Recurrent respiratory infections in children: a practical approach for clinical work. Pediatr Pulmonol Suppl, 1997, 16: 144-5. [PubMed: 9443246].Patria MF, Tagliabue C, Longhi B, Esposito S.Influenza vaccination in children at high risk of respiratory disease. Ther Adv Vaccines, 2013, 1(1):21-31. doi: 10.1177/2051013613480770. [PubMed: 24757513].Patria MF, Tagliabue C, Longhi B, Esposito S.Influenza vaccination in children at high risk of respiratory disease. Ther Adv Vaccines, 2013, 1(1):21-31. doi: 10.1177/2051013613480770. [PubMed: 24757513].Graham NM. The epidemiology of acute respiratory infections in children and adults: a global perspective. Epidemiol Rev. 1990, 12: 149-78. [PubMed: 2286216]Graham NM. The epidemiology of acute respiratory infections in children and adults: a global perspective. Epidemiol Rev. 1990, 12: 149-78. [PubMed: 2286216]Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis, 1989, 160(1): 83-94. [PubMed: 2732519]Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis, 1989, 160(1): 83-94. [PubMed: 2732519]Study Group of the Italian Society of Pediatric Immunology. Recurrent infections in children: definition and diagnostic approach. Rev Immunol Allerg Pediatr, 1988, 2: 127-34.Study Group of the Italian Society of Pediatric Immunology. Recurrent infections in children: definition and diagnostic approach. Rev Immunol Allerg Pediatr, 1988, 2: 127-34.Wheeler JG. Evaluating the child with recurrent infections. Am Fam Physician, 1996, 54(7): 2276–82. [PubMed: 8940960]Wheeler JG. Evaluating the child with recurrent infections. Am Fam Physician, 1996, 54(7): 2276–82. [PubMed: 8940960]Kilic SS. Recurrent respiratory tract infection. Recent advances in pediatrics. New Delhi: Jaypee Brothers Medical Publishers, 2004: 1-18.Kilic SS. Recurrent respiratory tract infection. Recent advances in pediatrics. New Delhi: Jaypee Brothers Medical Publishers, 2004: 1-18.Yang KD, Hill HR. Neutrophil function disorders: Pathophysiology, prevention, and therapy. J Pediatr, 1991, 119(3): 343-54. doi: 10.1016/s0022-3476(05)82044-x. [PubMed: 1880645]Yang KD, Hill HR. Neutrophil function disorders: Pathophysiology, prevention, and therapy. J Pediatr, 1991, 119(3): 343-54. doi: 10.1016/s0022-3476(05)82044-x. [PubMed: 1880645]Wheeler JG, Steiner D. Evaluation of humoral responsiveness in children. Pediatr Infect Dis J, 1992, 11(4): 304-10. [PubMed: 1565555]Wheeler JG, Steiner D. Evaluation of humoral responsiveness in children. Pediatr Infect Dis J, 1992, 11(4): 304-10. [PubMed: 1565555]Diesner SC, Forster-Waldl E, Olivera A, Pollak A, Jensen-Jarolim E, Untersmayr E. Perspectives on immunomodulation early in life. Pediatr Allergy Immunol, 2012, 23(3): 210-23. doi: 10.1111/j.1399- 3038.2011.01259.x. [PubMed: 22299601]Diesner SC, Forster-Waldl E, Olivera A, Pollak A, Jensen-Jarolim E, Untersmayr E. Perspectives on immunomodulation early in life. Pediatr Allergy Immunol, 2012, 23(3): 210-23. doi: 10.1111/j.1399- 3038.2011.01259.x. [PubMed: 22299601]Zhang Y, Zhang Y, Gu W, He L, Sun B. Th1/Th2 cell’s function in immune system. Adv Exp Med Biol. 2014, 841: 45-65. doi: 10.1007/978-94-017-9487-9_3. [PubMed: 25261204]Zhang Y, Zhang Y, Gu W, He L, Sun B. Th1/Th2 cell’s function in immune system. Adv Exp Med Biol. 2014, 841: 45-65. doi: 10.1007/978-94-017-9487-9_3. [PubMed: 25261204]Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Commit tee on Immunization Practices (ACIP) – United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep, 2014, 63(32): 691-7. [PubMed: 25121712]Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Commit tee on Immunization Practices (ACIP) – United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep, 2014, 63(32): 691-7. [PubMed: 25121712]Fete T. Respiratory problems in patients with ectodermal dysplasia syndromes. Am J Med Genet A, 2014, 164A(10): 2478–81. doi: 10.1002/ajmg.a.36600. [PubMed: 24842607]Fete T. Respiratory problems in patients with ectodermal dysplasia syndromes. Am J Med Genet A, 2014, 164A(10): 2478–81. doi: 10.1002/ajmg.a.36600. [PubMed: 24842607]Torres LC, Sugayama SM, Arslanian C, Sales MM, Carneiro-Sampaio M. Evaluation of the immune humoral response of Brazilian patients with Rubinstein-Taybi syndrome. Braz J Med Biol Res, 2010, 43(12): 1215-24. [PubMed: 21085895]Torres LC, Sugayama SM, Arslanian C, Sales MM, Carneiro-Sampaio M. Evaluation of the immune humoral response of Brazilian patients with Rubinstein-Taybi syndrome. Braz J Med Biol Res, 2010, 43(12): 1215-24. [PubMed: 21085895]Koshy E, Watt H, Curcin V, Bottle A, Sharland M, Saxena S. Tonsillectomy among children with low baseline acute throat infection consultation rates in UK general practices: a cohort study. BMJ Open, 2015, 5(2): e006686. doi: 10.1136/bmjopen-2014-006686. [PubMed: 25649213]Koshy E, Watt H, Curcin V, Bottle A, Sharland M, Saxena S. Tonsillectomy among children with low baseline acute throat infection consultation rates in UK general practices: a cohort study. BMJ Open, 2015, 5(2): e006686. doi: 10.1136/bmjopen-2014-006686. [PubMed: 25649213]van den Aardweg MT, Boonacker CW, Rovers MM, Hoes AW, Schilder AG. Effectiveness of adenoidectomy in children with recurrent upper respiratory tract infections: open randomised controlled trial. BMJ, 2011, 343: d5154. doi:10.1136/bmj.d5154. [PubMed: 21896611]van den Aardweg MT, Boonacker CW, Rovers MM, Hoes AW, Schilder AG. Effectiveness of adenoidectomy in children with recurrent upper respiratory tract infections: open randomised controlled trial. BMJ, 2011, 343: d5154. doi:10.1136/bmj.d5154. [PubMed: 21896611]Byington CL, Barnett ED, Davies HD, Edwards KM, Jackson MA, Maldonado YA, et al. Recommendations for Prevention and Control of Influenza in Children, 2014–2015. Pediatric, 2014, 134(5): e1503-19. [PubMed: 25246619]Byington CL, Barnett ED, Davies HD, Edwards KM, Jackson MA, Maldonado YA, et al. Recommendations for Prevention and Control of Influenza in Children, 2014–2015. Pediatric, 2014, 134(5): e1503-19. [PubMed: 25246619]Musher DM. How contagious are common respiratory tract infections? N Engl J Med, 2003, 348(13): 1256-66. doi: 10.1056/NEJMra021771.[PubMed: 12660390]Musher DM. How contagious are common respiratory tract infections? N Engl J Med, 2003, 348(13): 1256-66. doi: 10.1056/NEJMra021771.[PubMed: 12660390]Dales RE, Schweitzer I, Toogood JH, Drouin M, Yang W, Dolovich J, et al. Respiratory infections and the autumn increase in asthma morbidity. Eur Respir J, 1996, 9(1): 72-7. [PubMed: 8834337]Dales RE, Schweitzer I, Toogood JH, Drouin M, Yang W, Dolovich J, et al. Respiratory infections and the autumn increase in asthma morbidity. Eur Respir J, 1996, 9(1): 72-7. [PubMed: 8834337]Jackson DJ, Gangnon RE, Evans MD, Roberg KA,Anderson EL, Pappas TE, et al. Wheezing rhinovirus illnesses in early life predict asthma developmentin high-risk children. Am J Respir Crit Care Med, 2008, 178(7): 667-72. doi: 10.1164/rccm.200802-309OC. [PubMed: 18565953]Jackson DJ, Gangnon RE, Evans MD, Roberg KA,Anderson EL, Pappas TE, et al. Wheezing rhinovirus illnesses in early life predict asthma developmentin high-risk children. Am J Respir Crit Care Med, 2008, 178(7): 667-72. doi: 10.1164/rccm.200802-309OC. [PubMed: 18565953]Boyle P, Bellanto JA, Robertson C. Mela-analysis of published clinical trials of a ribosomal vaccine Ribomunyl® in prevention of respiratory infections. BioDrugs, 2000, 14: 389-408.Boyle P, Bellanto JA, Robertson C. Mela-analysis of published clinical trials of a ribosomal vaccine Ribomunyl® in prevention of respiratory infections. BioDrugs, 2000, 14: 389-408.

The authors declare that there are no conflicts of interest present.